ACADIA Pharmaceuticals Inc Financial Flexibility Index
ACADIA Pharmaceuticals Inc financial flexibility index. ACADIA Pharmaceuticals Inc (ACAD) has a Financial Flexibility Index of 0.33x as of June 2026. Free cash flow of $145.06 Million (operating CF $134.76 Million minus capex $10.30 Million) represents 0% of total liabilities ($436.29 Million). See ACADIA Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ACADIA Pharmaceuticals Inc (2002–2025)
Financial flexibility index of ACADIA Pharmaceuticals Inc from 2002 to 2025. Historical Financial Flexibility Index trend for ACADIA Pharmaceuticals Inc across 24 annual periods. Check ACADIA Pharmaceuticals Inc (ACAD) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
ACADIA Pharmaceuticals Inc Financial Flexibility Index by Year (2002–2025)
ACADIA Pharmaceuticals Inc financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for ACADIA Pharmaceuticals Inc. For the full cash flow conversion analysis, see how efficiently does ACADIA Pharmaceuticals Inc generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | $114.53 Million | $109.84 Million | $336.81 Million | ▼ -2.2% |
| 2024 | 0.35x | $158.24 Million | $157.72 Million | $454.96 Million | ▲ +94.4% |
| 2023 | 0.18x | $56.75 Million | $16.70 Million | $317.20 Million | ▲ +129.4% |
| 2022 | -0.61x | $-114.03 Million | $-114.03 Million | $187.40 Million | ▲ +22.2% |
| 2021 | -0.78x | $-124.54 Million | $-125.66 Million | $159.23 Million | ▲ +5.3% |
| 2020 | -0.83x | $-128.58 Million | $-136.17 Million | $155.61 Million | ▲ +53.7% |
| 2019 | -1.78x | $-150.00 Million | $-151.13 Million | $84.05 Million | ▲ +34.0% |
| 2018 | -2.70x | $-165.32 Million | $-167.47 Million | $61.12 Million | ▲ +38.7% |
| 2017 | -4.41x | $-217.04 Million | $-217.86 Million | $49.22 Million | ▲ +6.2% |
| 2016 | -4.70x | $-200.90 Million | $-210.41 Million | $42.74 Million | ▲ +13.1% |
| 2015 | -5.41x | $-119.65 Million | $-121.80 Million | $22.13 Million | ▼ -30.3% |
| 2014 | -4.15x | $-66.25 Million | $-66.43 Million | $15.97 Million | ▲ +6.9% |
| 2013 | -4.46x | $-31.15 Million | $-31.77 Million | $6.99 Million | ▼ -386.6% |
| 2012 | -0.92x | $-21.63 Million | $-21.63 Million | $23.61 Million | ▲ +59.7% |
| 2011 | -2.27x | $-19.89 Million | $-19.90 Million | $8.75 Million | ▼ -84.9% |
| 2010 | -1.23x | $-10.70 Million | $-10.70 Million | $8.71 Million | ▼ -237.4% |
| 2009 | -0.36x | $-13.69 Million | $-13.73 Million | $37.57 Million | ▲ +93.4% |
| 2008 | -5.53x | $-64.64 Million | $-64.87 Million | $11.69 Million | ▼ -109.6% |
| 2007 | -2.64x | $-54.51 Million | $-54.93 Million | $20.65 Million | ▼ -50.0% |
| 2006 | -1.76x | $-39.39 Million | $-41.42 Million | $22.39 Million | ▼ -111.6% |
| 2005 | -0.83x | $-19.24 Million | $-20.26 Million | $23.13 Million | ▲ +59.9% |
| 2004 | -2.08x | $-20.11 Million | $-20.69 Million | $9.68 Million | ▼ -2078.9% |
| 2003 | -0.10x | $-8.04 Million | $-9.82 Million | $84.36 Million | ▲ +39.7% |
| 2002 | -0.16x | $-8.86 Million | $-9.24 Million | $56.11 Million | — |